Pharma Mar | PHM - Loan Capital

Stock Price
96.10
Daily Change
-0.20 -0.21%
Monthly
1.37%
Yearly
18.94%
Q2 Forecast
93.78

Pharma Mar reported EUR33.16M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Almirall EUR 324.81M 61.32M Dec/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Moderna USD 603M 7M Mar/2026
Organon & Co USD 8.55B 75M Mar/2026
Pharma Mar EUR 33.16M 3.52M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.41B 67.1M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026